These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7320220)

  • 21. Deranged renal function in liver disease.
    Epstien M
    Contrib Nephrol; 1977; 7():250-71. PubMed ID: 330107
    [No Abstract]   [Full Text] [Related]  

  • 22. Liver Cirrhosis and Kidney.
    Gerbes AL
    Dig Dis; 2016; 34(4):387-90. PubMed ID: 27170393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal damage in liver cirrhosis: pathophysiology and management].
    Yamamoto T; Hishida A
    Nihon Rinsho; 1994 Jan; 52(1):159-64. PubMed ID: 8114286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Physiopathology and treatment of ascites in the cirrhotic patient].
    Rodés J; Arroyo V
    Rev Med Brux; 1987 Apr; 8(4):204-8. PubMed ID: 3589268
    [No Abstract]   [Full Text] [Related]  

  • 25. [The hepatorenal syndrome: etiopathogenetic, clinical and therapeutic considerations].
    Mancinella A
    Clin Ter; 1976 Dec; 79(6):583-90. PubMed ID: 795602
    [No Abstract]   [Full Text] [Related]  

  • 26. The kidney in infectious diseases.
    Perspect Nephrol Hypertens; 1976; 3():203-21. PubMed ID: 129758
    [No Abstract]   [Full Text] [Related]  

  • 27. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis.
    Ring-Larsen H; Palazzo U
    Gut; 1981 Jul; 22(7):585-91. PubMed ID: 7262632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of ascites in patients with chronic liver disease.
    Aiza I; Perez GO; Schiff ER
    Am J Gastroenterol; 1994 Nov; 89(11):1949-56. PubMed ID: 7942716
    [No Abstract]   [Full Text] [Related]  

  • 29. [Glomerular lesions and hepatopathies].
    Nochy D; Druet P
    Minerva Med; 1978 Oct; 69(47):3243-8. PubMed ID: 152421
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventing and Treating Acute Kidney Injury Among Hospitalized Patients with Cirrhosis and Ascites: A Narrative Review.
    Tapper EB; Bonder A; Cardenas A
    Am J Med; 2016 May; 129(5):461-7. PubMed ID: 26724589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal failure in cirrhosis: prerenal azotemia, hepatorenal syndrome and acute tubular necrosis.
    Schrier RW; Shchekochikhin D; Ginès P
    Nephrol Dial Transplant; 2012 Jul; 27(7):2625-8. PubMed ID: 22492830
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute tubular necrosis vs. perfusion nephropathy.
    Kjellstrand CM
    N Engl J Med; 1977 May; 296(21):1233. PubMed ID: 323709
    [No Abstract]   [Full Text] [Related]  

  • 33. [New views on the pathogenesis and therapy of ascites in liver cirrhosis].
    Dölle W
    Internist (Berl); 1971 Aug; 12(8):332-3. PubMed ID: 4936456
    [No Abstract]   [Full Text] [Related]  

  • 34. [Organic nephropathies in patients with liver diseases].
    Amoedo ML; Montoliu J
    Gastroenterol Hepatol; 1996 Mar; 19(3):167-77. PubMed ID: 8991663
    [No Abstract]   [Full Text] [Related]  

  • 35. Tubular handling of sodium and phosphate in cirrhosis with salt retention.
    Rochman J; Chaimovitz C; Szylman P; Better OS
    Nephron; 1978; 20(2):95-100. PubMed ID: 622215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 9- -fluorohydrocortisone induced ascites in alcoholic liver disease.
    Denison EK; Lieberman FL; Reynolds TB
    Gastroenterology; 1971 Oct; 61(4):497-503. PubMed ID: 5114641
    [No Abstract]   [Full Text] [Related]  

  • 37. Volume homoeostasis in cirrhosis of the liver. Pathogenetic and therapeutic implications.
    Koomans HA; Van Hattum J; Speelberg B
    Neth J Med; 1986; 29(7):212-20. PubMed ID: 3528875
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis of ascites in cirrhosis.
    Arroyo V; Badalamenti S; Ginès P
    Minerva Med; 1987 May; 78(10):645-50. PubMed ID: 3587709
    [No Abstract]   [Full Text] [Related]  

  • 39. Pros and cons of TIPS for refractory ascites.
    Sanyal AJ
    J Hepatol; 2005 Dec; 43(6):924-5. PubMed ID: 16246451
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of prostaglandins in hepatic cirrhosis with ascites].
    Pacheco D; Zamorano B; Feller A
    Rev Med Chil; 1986 Oct; 114(10):978-83. PubMed ID: 3575940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.